UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction

Cancer research (Chicago, Ill.), 2017-08, Vol.77 (16), p.4328-4341

2017

Volltextzugriff (PDF)

SPOP mutation induces DNA methylation via stabilizing GLP/G9a

Nature communications, 2021-09, Vol.12 (1), p.5716-5716, Article 5716

2021

Volltextzugriff (PDF)

HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer

Cancer research (Chicago, Ill.), 2021-03, Vol.81 (6), p.1486-1499

2021

Volltextzugriff (PDF)

Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression

Scientific reports, 2017-03, Vol.7 (1), p.43864-43864, Article 43864

2017

Volltextzugriff (PDF)

TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53 -Mutated Prostate Cancer

Clinical cancer research, 2018-09, Vol.24 (18), p.4551-4565

2018

Volltextzugriff (PDF)

3-Aminophthalic acid, a new cereblon ligand for targeted protein degradation by O'PROTAC

Chemical communications (Cambridge, England), 2022-02, Vol.58 (14), p.2383-2386

2022

Volltextzugriff (PDF)

Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation

Molecular cell, 2015-09, Vol.59 (6), p.904-916

2015

Volltextzugriff (PDF)

Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis

Nature communications, 2023-08, Vol.14 (1), p.4671-19, Article 4671

2023

Volltextzugriff (PDF)

Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion

Cancer research (Chicago, Ill.), 2017-12, Vol.77 (23), p.6524-6537

2017

Volltextzugriff (PDF)

p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Cancer research (Chicago, Ill.), 2014-03, Vol.74 (6), p.1870-1880

2014

Volltextzugriff (PDF)

The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer

EMBO molecular medicine, 2019-11, Vol.11 (11), p.e10659-n/a

2019

Volltextzugriff (PDF)

TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks

Nature communications, 2023-03, Vol.14 (1), p.1810-1810, Article 1810

2023

Volltextzugriff (PDF)

FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (9), p.3257-3267

2011

Volltextzugriff (PDF)

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer

Oncotarget, 2016-01, Vol.7 (3), p.3440-3452

2016

Volltextzugriff (PDF)

Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer

EMBO molecular medicine, 2018-04, Vol.10 (4), p.n/a

2018

Volltextzugriff (PDF)

P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth

Oncotarget, 2016-03, Vol.7 (12), p.15135-15149

2016

Volltextzugriff (PDF)

Inhibition of Cyclin-Dependent Kinase Phosphorylation of FOXO1 and Prostate Cancer Cell Growth by a Peptide Derived from FOXO1

Neoplasia (New York, N.Y.), 2011-09, Vol.13 (9), p.854-863

2011

Volltextzugriff (PDF)

CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (7), p.2050-2061

2014

Volltextzugriff (PDF)

Androgens repress expression of the f-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells

The Prostate, 2012-02, Vol.72 (2), p.225-232

2012

Volltextzugriff (PDF)

PTEN Induces Chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression

The Journal of biological chemistry, 2001-10, Vol.276 (42), p.38830-38836

2001

Volltextzugriff (PDF)

Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells

Cancer letters, 2004-09, Vol.213 (2), p.155-163

2004

Volltextzugriff (PDF)

Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice

Carcinogenesis (New York), 2008-03, Vol.29 (3), p.610-619

2008

Volltextzugriff (PDF)

Mutated SPOP E3 ligase promotes 17βHSD4 protein degradation to drive androgenesis and prostate cancer progression

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13), p.3593-3606

2021

Volltextzugriff (PDF)

SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (6), p.875-889

2023

Volltextzugriff (PDF)

DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1

Molecular cell, 2020-09, Vol.79 (6), p.1008-1023.e4

2020

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

ThemaCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(63)
Tagungsberichte
(3)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction

SPOP mutation induces DNA methylation via stabilizing GLP/G9a

HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer

Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression

TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53 -Mutated Prostate Cancer

3-Aminophthalic acid, a new cereblon ligand for targeted protein degradation by O'PROTAC

Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation

Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis

Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion

p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer

TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks

FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer

Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer

P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth

Inhibition of Cyclin-Dependent Kinase Phosphorylation of FOXO1 and Prostate Cancer Cell Growth by a Peptide Derived from FOXO1

CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy

Androgens repress expression of the f-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells

PTEN Induces Chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression

Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells

Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice

Mutated SPOP E3 ligase promotes 17βHSD4 protein degradation to drive androgenesis and prostate cancer progression

SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors

DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1

Aktive Filter

Suchergebnisse filtern